BlackRock Fund Advisors’s Novavax NVAX Stock Holding History

BlackRock Fund Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.2M	Buy	603,350 +68,111	+13%	+$1.99M	﹤0.01%	2333
2016 Q3	$22.3M	Buy	535,239 +27,471	+5%	+$3.55M	﹤0.01%	2016
2016 Q2	$73.8M	Buy	507,768 +599	+0.1%	+$68.7K	0.02%	1223
2016 Q1	$52.3M	Buy	507,169 +8,258	+2%	+$886K	0.01%	1426
2015 Q4	$83.7M	Sell	498,911 -22,987	-4%	-$3.54M	0.02%	1099
2015 Q3	$73.8M	Buy	521,898 +25,501	+5%	+$5.72M	0.02%	1145
2015 Q2	$111M	Buy	496,397 +40,516	+9%	+$7.12M	0.03%	908
2015 Q1	$75.4M	Buy	455,881 +10,267	+2%	+$1.67M	0.02%	1214
2014 Q4	$52.9M	Buy	445,614 +43,444	+11%	+$4.54M	0.01%	1429
2014 Q3	$33.5M	Buy	402,170 +47,714	+13%	+$4.31M	0.01%	1624
2014 Q2	$32.8M	Sell	354,456 -33,716	-9%	-$2.96M	0.01%	1691
2014 Q1	$35.2M	Buy	388,172 +15,037	+4%	+$1.68M	0.01%	1649
2013 Q4	$38.2M	Buy	373,135 +91,173	+32%	+$6.44M	0.01%	1587
2013 Q3	$17.8M	Buy	281,962 +43,182	+18%	+$2.43M	0.01%	2040
2013 Q2	$9.79M	Buy	+238,780	New	+$10.3M	﹤0.01%	2272

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $917M AUM 3.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Fund Advisors's NVAX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Novavax (NVAX) stake by 13% in Q4 2016, buying an estimated $1.99M and bringing the position to 603,350 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

BlackRock Fund Advisors first reported a position in NVAX in Q2 2013 and has held it in 15 quarters since. The position peaked at $111M in Q2 2015. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

BlackRock Fund Advisors held 603,350 shares of Novavax worth $15.2M as of Q4 2016.
BlackRock Fund Advisors bought 68,111 Novavax shares in Q4 2016, an estimated $1.99M.
Novavax made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2333 holding.
BlackRock Fund Advisors first reported a position in Novavax in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Novavax position peaked at $111M in Q2 2015.
143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.